The impact of mismatch repair status and systemic inflammatory markers on radiological staging in colon cancer.

OBJECTIVE

Mismatch repair (MMR) deficient (dMMR) colon cancer (CC) is distinct from MMR proficient (pMMR) CC, yet the impact of MMR status on radiological staging is unclear. The purpose of this study was to investigate how MMR status impacts CC CT staging.

METHODS

We retrospectively compared CT staging accuracy between dMMR and pMMR CC patients undergoing curative resection. Accuracy was assessed as individual tumour (T)/nodal (N) stages and as dichotomous "statuses" (T1/2 T3/4; N0 N1/2). Patient characteristics were analysed for factors to support staging.

RESULTS

There was no significant difference in overall staging accuracy between the dMMR (44 patients) and pMMR (57 patients) groups. dMMR tumours with incorrect N stage/"status" were more likely to be overstaged than pMMR tumours (90% 59%; = 0.023 for "N status"). Platelet count, CRP and neutrophil count (AUC 0.76 ( = 0.0078), 0.75 ( = 0.034) and 0.70 ( = 0.044), respectively) were associated with "N status" in dMMR tumours.

CONCLUSION

Whilst overall staging accuracy was similar between groups, incorrectly N staged dMMR tumours were more likely to be overstaged than pMMR tumours, risking inappropriate surgical or neoadjuvant treatment. We describe novel relationships between several inflammatory markers and pathological "N status" in dMMR CC, which if integrated into routine practice may improve CT staging accuracy.

ADVANCES IN KNOWLEDGE

Compared to pMMR CC, dMMR CC is at significant risk of N overstaging. Platelet count, CRP and neutrophil count are higher in dMMR CC patients with nodal metastases than those without, and their role in refining clinical staging requires further investigation.